Loading…
Kwality Pharmaceuticals (KPL)₹3,856+4.62%Pharmaceuticals
At the end of the Jun 2026 quarter, Kwality Pharmaceuticals' shareholders were: promoters 54.91%, FIIs 3.12%, DIIs 0.56%, public 41.41%. Promoter holding is down 0.01 percentage points from 54.92% a quarter earlier. FII holding is up 3.12 percentage points from 0.00% a year earlier. 0.00% of promoter shares were pledged. It had 13,284 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 54.81% | 54.81% | 54.87% | 54.87% | 54.87% | 54.87% | 54.87% | 54.87% | 54.87% | 54.87% | 54.92% | 54.91% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.50% | 2.78% | 3.12% |
| DIIs | 0.01% | 0.01% | 0.00% | 0.00% | 0.02% | 0.03% | 0.32% | 0.33% | 0.33% | 0.33% | 0.36% | 0.56% |
| Public | 45.18% | 45.18% | 45.13% | 45.13% | 45.11% | 45.10% | 44.81% | 44.80% | 44.80% | 44.30% | 41.94% | 41.41% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 6,293 | 5,788 | 5,697 | 5,275 | 7,490 | 8,950 | 9,423 | 10,119 | 11,599 | 10,713 | 10,559 | 13,284 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Ramesh Arora | Promoter | 26.00% | 0.00 |
| Ajay Arora | Promoter | 13.59% | 0.00 |
| Aditya Arora | Promoter | 11.99% | 0.00 |
| Deepak Bansal | Public | 8.33% | −0.85 |
| Manohar Devabhaktuni | Public | 5.01% | 0.00 |
| Ark Global Emerging Companies, Lp | FII | 2.10% | 0.00 |
| Kadayam Ramnathan Bharat | Public | 1.97% | 0.00 |
| Dheeraj Kumar Lohia | Public | 1.65% | −0.20 |
| Jani Bhasha Shaik | Public | 1.44% | 0.00 |
| Anju Arora | Promoter | 1.30% | 0.00 |
| Geeta Arora | Promoter | 1.08% | 0.00 |
| Onkar Singh | Public | 1.08% | 0.00 |
| Jugal Kishore Huf | Promoter | 0.88% | 0.00 |
Promoters held 54.91% of Kwality Pharmaceuticals at the end of the Jun 2026 quarter, up 0.04 percentage points from 54.87% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 3.12% (up 0.34 percentage points from 2.78% a quarter earlier) and domestic institutions (DIIs) held 0.56% (up 0.20 percentage points from 0.36% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Kwality Pharmaceuticals had 13,284 shareholders at the end of the Jun 2026 quarter, against 10,119 a year earlier.
Deepak Bansal (Public) held 8.33% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.